Skip to main content
TMHCTaylor Morrison Home CorporatioSell4.4·$71.93+0.39%
TMHC · Why this verdict

Why Taylor Morrison Home Corporatio (TMHC) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score4.4/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Taylor Morrison Home has beaten earnings estimates in 3 of the last 4 quarters and trades at a forward price-to-earnings of 11.2x, but with the stock at RSI 93, negative revenue growth of -27%, and the price above the analyst target, the risk-reward is firmly negative for new entry.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Taylor Morrison has beaten earnings estimates in three of the last four quarters with an average positive surprise of 12.6%, while trading at a forward price-to-earnings of 11.2x — suggesting the market has not fully valued the company's earnings delivery track record.

Stable
Earnings
Expectation
Beat count reaches at least 3 of the next 4 quarters and forward price-to-earnings expands above 13x as the earnings track record is recognized.

CounterRevenue is declining 27% year-over-year, which means the earnings beats are occurring on a shrinking revenue base — a pattern that typically cannot be sustained without top-line recovery.

Revenue declined 27% year-over-year, earning a growth score of 0.0 out of 10, and earnings growth is also at 0.0 — the worst combination in the scoring model — indicating the company is currently in a meaningful contraction phase.

Stable
Growth
Expectation
Revenue growth recovers above 0% year-over-year within 12 months, removing the 0.0 growth score and establishing a positive trajectory.

CounterResidential construction revenue can be lumpy due to community closeouts and opening timing, and a single-quarter revenue decline may not reflect the underlying order backlog or future delivery pipeline.

RSI at 93 is extremely overbought and falls in the top 1% of historical readings, while falling on-balance volume at a near-52-week high signals late-cycle distribution — a pattern where large sellers are offloading shares into strength.

Stable
Momentum breakdown
Expectation
RSI falls below 70 within 60 days as the stock consolidates from the overbought condition, and on-balance volume stabilizes or turns positive.

CounterRSI can remain elevated for extended periods during strong uptrends, and the golden cross MACD pattern suggests the underlying trend may support the elevated RSI reading temporarily.

The current price of $71.95 is above the analyst price target with -21.6% implied downside, and news sentiment of -0.50 combined with an elevated put/call ratio of 1.68 indicates that both the analyst community and options market are cautious on near-term prospects.

Stable
Bear case
Expectation
Analyst consensus price target rises above $78, more than 8% above the current price of $71.95, re-establishing positive asymmetry before any new position is considered.

CounterA C-suite officer departure or appointment — flagged in the 8-K warning — could signal strategic change that improves the outlook beyond what current analyst targets reflect.

Per-dimension breakdown

Value

7.0/10data confidence 83%
ComponentSub-score
P/E8.9
P/S9.7
EV/EBITDA7.0
Fwd P/E9.1
Analyst target3.0
  • Forward P/E: 11.2x
  • Attractively valued

Quality

4.3/10data confidence 100%
ComponentSub-score
ROE3.7
ROA4.4
Gross margin0.5
Op margin4.5
Net margin4.4
Current ratio5.0
FCF quality5.7
Moat3.9
Piotroski F6.7
  • Earnings quality warning: 75% FCF/NI
  • No competitive moat

Growth

0.0/10data confidence 67%
ComponentSub-score
Rev growth0.0
EPS growth0.0
  • Declining revenue: -27%

Momentum

4.8/10data confidence 100%
ComponentSub-score
RSI5.0
MACD0.0
OBV10.0
MA position8.0
Volume1.0
  • Volume accumulation (rising OBV)
  • Above 200-MA but MA slope flat

Sentiment

4.8/10data confidence 100%
ComponentSub-score
Analyst rating5.0
Price target3.9
erm sentiment5.5

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.1
  • No net insider activity — $0 (0.000% of mkt cap)

Peer rank

3.2/10data confidence 80%
ComponentSub-score
value rank7.5
quality rank4.7
growth rank0.6
  • Attractive P/E vs peers

Technical

4.6/10data confidence 100%
ComponentSub-score
bollinger3.8
support resistance0.2
52w position9.8

Risk (lower is worse)

7.0/10data confidence 100%
ComponentSub-score
short interest5.9
days to cover5.4
volatility10.0
put call10.0
implied vol7.8
max pain risk3.0
beta5.1
debt equity8.5
  • Above max pain $45

Catalyst

6.4/10data confidence 100%
ComponentSub-score
erm5.0
earnings history6.7
earnings timing5.0
surprise avg8.9
  • Strong earnings: 3B/1M

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (6)
  • MOMENTUM:4.8>=4.5
  • INSIDER:OK
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:28d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-1.3=NEGATIVE
Warning (2)
  • MOMENTUM:4.8<5.5 (soft — BUY_NOW allowed but watch)
  • 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-1.29
Upside
-19.3%
Downside
15.0%
Sizing output
AVOID

SetupUNKNOWN No clear chart pattern; technical signals are mixed

EdgeCATALYST Earnings in 28d with 3/4 beat streak

SuitabilityAGGRESSIVE Beta 1.48>1.3

Investment implication

The F-path SELL output reflects an overall score of 4.4 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 7.0) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.3=NEGATIVE) reinforce the read. Current asymmetry R:R is -1.29 — supplementary context, not the trigger for this path.

The strongest dimensions are Value at 7.0, Risk (lower is worse) at 7.0, and Catalyst at 6.4; the weakest are Growth at 0.0, Peer rank at 3.2, and Quality at 4.3. The V9 engine flagged 1 failed gate with 2 warnings, producing an asymmetric reward-to-risk of -1.29 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Taylor Morrison has beaten earnings estimates in three of the last four quarters with an average positive surprise of 12.6%, while trading at a forward price-to-earnings of 11.2x — suggesting the market has not fully valued the company's earnings delivery track record.

    Trip ifEPS surprise falls below 0% in at least 2 of the next 4 quarters, confirming that the beat streak has broken down as revenue contraction pressures the bottom line.

  • P2RSI at 93 is extremely overbought and falls in the top 1% of historical readings, while falling on-balance volume at a near-52-week high signals late-cycle distribution — a pattern where large sellers are offloading shares into strength.

    Trip ifRSI remains above 80 for more than 30 consecutive trading days while on-balance volume continues to fall, confirming sustained overbought distribution rather than a temporary peak.

  • P3Revenue declined 27% year-over-year, earning a growth score of 0.0 out of 10, and earnings growth is also at 0.0 — the worst combination in the scoring model — indicating the company is currently in a meaningful contraction phase.

    Trip ifRevenue growth falls below -30% year-over-year in the next reported quarter, declining more than 3 percentage points below the already-negative -27% pace.

  • P4The current price of $71.95 is above the analyst price target with -21.6% implied downside, and news sentiment of -0.50 combined with an elevated put/call ratio of 1.68 indicates that both the analyst community and options market are cautious on near-term prospects.

    Trip ifAnalyst consensus price target falls below $60, more than 16% below the current price of $71.95, confirming that downside risk has increased beyond the current negative-asymmetry situation.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks TMHC Why this verdict